Related Experiment Video

Updated: Jul 14, 2026

A High-throughput Shigella-specific Bactericidal Assay
06:11

A High-throughput Shigella-specific Bactericidal Assay

Published on: February 27, 2019

Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road

Myron M Levine1, Karen L Kotloff, Eileen M Barry

  • 1Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. mlevine@medicine.umaryland.edu

Nature Reviews. Microbiology
|June 15, 2007
PubMed

Insights

Developing a safe and effective Shigella vaccine remains a challenge despite 50 years of research. This review covers advanced Shigella vaccine strategies, immune responses, and development hurdles.

Area of Science:

  • * Microbiology and Immunology
  • * Vaccine Development and Infectious Diseases

Background:

  • * Shigellosis remains a significant global health concern, particularly in developing countries.
  • * Despite extensive research over 50 years, a widely applicable Shigella vaccine has not yet been achieved.

Purpose of the Study:

  • * To review advanced strategies for Shigella vaccine development.
  • * To discuss immune responses to Shigella infection and vaccination.
  • * To identify factors influencing Shigella vaccine progress and propose future directions.

Main Methods:

  • * Comprehensive literature review of Shigella vaccine research.
  • * Analysis of immunological data from disease and vaccination studies.
  • * Evaluation of historical and current vaccine development challenges.

Main Results:

  • * Numerous Shigella vaccine candidates have shown promise but faced development impediments.
  • * Understanding of immune responses to Shigella is crucial for effective vaccine design.
  • * Factors such as safety, efficacy, and manufacturing have hindered widespread use.

Conclusions:

  • * Advanced strategies are being explored to overcome Shigella vaccine development challenges.
  • * Further research into immune mechanisms and innovative approaches is needed.
  • * Attaining a safe and effective Shigella vaccine for global use requires continued scientific effort.

More Related Videos

Epithelial Cell Infection Analyses with Shigella04:56

Epithelial Cell Infection Analyses with Shigella

Published on: February 9, 2024

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccinations01:51

Vaccinations

Overview